12
Views
9
CrossRef citations to date
0
Altmetric
Original

Therapy of Melanoma with Allogeneic Melanoma Lysates Alone or with Interferon-Alfa

, &
Pages 759-768 | Published online: 17 Jul 2002

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Robert O. Dillman, Gabriel I. Nistor & Hans S. Keirstead. (2023) Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines. Human Vaccines & Immunotherapeutics 19:1.
Read now
Oliver Klein, Christopher Schmidt, Ashley Knights, Ian D Davis, Weisan Chen & Jonathan Cebon. (2011) Melanoma vaccines: developments over the past 10 years. Expert Review of Vaccines 10:6, pages 853-873.
Read now
Anna C Pavlick, Sylvia Adams, Matthew A Fink & Amanda Bailes. (2003) Novel therapeutic agents under investigation for malignant melanoma. Expert Opinion on Investigational Drugs 12:9, pages 1545-1558.
Read now

Articles from other publishers (6)

Kevin D. Pavelko, Karin L. Heckman, Michael J. Hansen & Larry R. Pease. (2008) An Effective Vaccine Strategy Protective against Antigenically Distinct Tumor Variants. Cancer Research 68:7, pages 2471-2478.
Crossref
Malcolm S. Mitchell. (2007) In Reply. Journal of Clinical Oncology 25:29, pages 4693-4695.
Crossref
Malcolm S. MitchellJudith AbramsJohn A. ThompsonMohammed Kashani-SabetRonald C. DeContiWen-Jen HwuMichael B. AtkinsEric WhitmanMarc S. ErnstoffFrank G. HaluskaJames G. JakowatzTapas K. Das GuptaJon M. RichardsWolfram E. SamlowskiJohn J. CostanziFrederick R. AronsonAlbert B. DeisserothArkadiusz Z. DudekVicky E. Jones. (2007) Randomized Trial of an Allogeneic Melanoma Lysate Vaccine With Low-Dose Interferon Alfa-2b Compared With High-Dose Interferon Alfa-2b for Resected Stage III Cutaneous Melanoma. Journal of Clinical Oncology 25:15, pages 2078-2085.
Crossref
Peter Hersey, Scott W. Menzies, Brendon Coventry, Tam Nguyen, Margaret Farrelly, Susan Collins, Debbie Hirst & Heather Johnson. (2004) Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma. Cancer Immunology, Immunotherapy 54:3, pages 208-218.
Crossref
David Avigan. (2004) Dendritic Cell-Tumor Fusion Vaccines for Renal Cell Carcinoma. Clinical Cancer Research 10:18, pages 6347S-6352S.
Crossref
Malcolm S. Mitchell, June Kan-Mitchell, Philip R. Morrow, Denise Darrah, Vicky E. Jones & Matthew F. Mescher. (2004) Phase I Trial of Large Multivalent Immunogen Derived from Melanoma Lysates in Patients with Disseminated Melanoma. Clinical Cancer Research 10:1, pages 76-83.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.